Abstract:BACKGROUND:Schwannomatosis is a recently recognized peripheral nerve polyneoplasm with clinical characteristics and a genetic background that differ from those of neurofibromatosis 2 (NF2). The diagnostic and treatment criteria of this rare disorder are herein discussed.METHODS:The data of 180 patients who underwent operations for benign schwannomas from 2003 to 2012 in our center were reviewed. Eight of them were classified as schwannomatosis according to the diagnostic criteria suggested by MacCollin. The demographic characteristics were documented and compared between the two groups of patients. The patients' clinical presentations, imaging characteristics, histological features, and treatment results were retrospectively investigated and summarized.RESULTS:Of the 180 cases of benign schwannomas we reviewed this time, eight patients presented with schwannomatosis (4.44%). The mean age of the two groups was not significantly different (40.0 vs. 44.7 years, t = 0.88, P = 0.378). However, schwannnomatosis seems to more generally occur in females (75% vs. 48% were females, P = 0.162), although the difference was not statistically significant. The initial main symptom was pain. The neurological examination was otherwise normal. Magnetic resonance imaging (MRI) revealed multiple discrete, well-defined round, or oval lesions distributed along the course of the peripheral nerves in the extremities with low-to-intermediate signal intensity on T1-weighted images and high-signal intensity on T2-weighted images. Vestibular schwannomas were excluded in four patients by cranial MRI. The lesions in all patients were resected and were pathologically proven to be schwannomas. The average follow-up period was 26 months. Six individuals obtained a good result without symptoms or function loss.CONCLUSIONS:Schwannomatosis is characterized by the development of multiple schwannomas without evidence of the vestibular tumors that are diagnostic for NF2. It commonly occurs in middle-aged females. It has similar demographic features to solitary benign schwannoma. Surgical resection always results in a good outcome.

Gene mutation at chromosome 22 in sporadic patients with spinal schwannomatosis: A preliminary analysis

The Analysis of NF2 Gene Mutation in Sporadic Schwannomas

Mutation Analysis of NF2 Gene and Clinical Investigation in a Chinese Family with Neurofibromatosis Type II

Genetic Analysis and Prenatal Diagnosis of a Sporadic Family with Neurofibromatosis Type 1

Whole Genome Sequencing Identifies Key Genes in Spinal Schwannoma

The Study of Molecular Genetics of Schwannomas

Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma

Identification of Genomic Alterations in Sporadic Pancreatic Neurogenic Tumors.

Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and Its Prognostic Impact on Tumour Growth Patterns

Biom-47. Single Nucleotide Polymorphism In Smarcb1 Mutation For Schwannomatosis

Analysis of families with hereditary neurofibromatosis type 2 gene mutation and clinical features

A Novel NF2 Mutation Associated with Neurofibromatosis Type 2 Causes Aberrant Splicing and Phase Separation

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

The effect of loss of heterozygosity on chromosome 22 on sporadic schwannoma

The mutation of exon 2 of neurofbromatosis 2 gene in Schwannoma and its significance

[Analysis of Gene Mutation in Patients with Tuberous Sclerosis Complex with Polymerase Chain Reaction-Single Strand Conformation Polymorphism].

Schwannomatosis: a New Member of Neurofibromatosis Family.

A novel leucine zipper-like transcriptional regulator 1 variant identified in a pair of siblings with familial schwannomatosis

The Role of NF2 Gene Mutations and Pathogenesis-Related Proteins in Sporadic Vestibular Schwannomas in Young Individuals.

Case Report: A Synonymous Mutation in <i>NF1</i> Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping

Clinical features and treatment analysis of schwannomatosis in central nervous system